SC
NVO

Steven Cohen’s Novo Nordisk NVO Stock Holding History

Steven Cohen’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.6M Buy
826,600
+645,600
+357% +$27.7M 0.04% 530
2026
Q1 		$6.65M Sell
181,000
-106,500
-37% -$5.05M 0.01% 1505
2025
Q4 		$14.6M Buy
287,500
+98,100
+52% +$5.02M 0.02% 1106
2025
Q3 		$10.5M Sell
189,400
-998,700
-84% -$58.5M 0.02% 778
2025
Q2 		$82M Buy
1,188,100
+1,034,500
+674% +$70.4M 0.16% 148
2025
Q1 		$10.7M Sell
153,600
-43,400
-22% -$3.58M 0.02% 659
2024
Q4 		$16.9M Buy
197,000
+49,600
+34% +$5.36M 0.04% 513
2024
Q3 		$17.6M Buy
147,400
+130,800
+788% +$17.4M 0.04% 461
2024
Q2 		$2.37M Sell
16,600
-100,000
-86% -$13.3M 0.01% 1049
2024
Q1 		$15M Buy
116,600
+16,600
+17% +$1.98M 0.04% 560
2023
Q4 		$10.3M Buy
+100,000
New +$9.89M 0.03% 670

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Steven Cohen's NVO Position: Q2 2026 in Review

Steven Cohen opened a new position in Novo Nordisk (NVO) in Q2 2026: 29,198 shares worth $1.4M. The stake represents ﹤0.01% of the portfolio and ranks #2614 among its holdings. This is a return to the name: Steven Cohen previously reported a position in NVO as recently as Q2 2024.

Steven Cohen first reported a position in NVO in Q4 2014 and has held it in 11 quarters since. The position peaked at $137M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Steven Cohen held 29,198 shares of Novo Nordisk worth $1.4M as of Q2 2026.
  • Novo Nordisk was a new Steven Cohen position in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2614 holding.
  • Steven Cohen first reported a position in Novo Nordisk in Q4 2014 and has held it in 11 quarters since.
  • Steven Cohen's Novo Nordisk position peaked at $137M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.